| Value | ₹0.03 Cr |
|---|
BSE filing, BSE: 540204. Summary written from the filing by ALFA Finder's alert engine.
Eiko Lifesciences Ltd: key numbers
- Share price
- ₹49.44
- Market cap
- ₹67.84 Cr
- Revenue (annual)
- ₹52.57 Cr
- Net profit (annual)
- ₹4.50 Cr
- P/E (TTM)
- 13.1×Sector 29.3×
- Promoter holding
- 39.96%+0.05% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Eiko Lifesciences Ltd
All →Eiko Lifesciences Merger & Restructuring
Eiko Lifesciences' wholly owned subsidiary Eiko Scientific Solutions LLP will form a 50:50 joint venture, Oval Eiko Resources, with Oval Projects Engineering. The JV targets compressed bio gas production and distribution.
Eiko Lifesciences Q2 FY27 Results: Net Profit ₹1.6 Cr, Up 23.1% YoY
Eiko Lifesciences Ltd reported revenue from operations of ₹17.7 Cr (+51.3% YoY) and net profit of ₹1.6 Cr (+23.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.6 Cr · +23.1% YoY
Eiko Lifesciences Board Meeting Date
Eiko Lifesciences has scheduled a board meeting for November 5, 2026, to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after the results.
Eiko Lifesciences Convertible Warrants
Eiko Lifesciences allotted 1,50,000 equity shares upon conversion of warrants, receiving a balance payment of Rs. 0.62 Crore from promoter Lenus Finvest Private Limited.
- Value
- ₹0.62 Cr
- From
- Lenus Finvest Private Limited
Eiko Lifesciences Other Announcement
The company submitted the Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent for the quarter ended September 30, 2026.
Eiko Lifesciences Annual General Meeting
Eiko LifeSciences held its 49th Annual General Meeting on September 22, 2026. The meeting transacted business, including adoption of financial statements and appointment of directors.
Other merger & restructuring announcements
All →Relaxo Footwears Merger & Restructuring Worth ₹35.7 Cr
Relaxo approved a Kenya joint venture, subscribing 51% for up to Rs.35.70 crore. The JV will become a subsidiary on completion.
- Value
- ₹35.70 Cr
- Execution
- Completion expected within approximately 60 to 90 days, and no later than 6 months from SSHA execution
Gujarat Alkalies & Chemicals Merger & Restructuring Worth ₹0 Cr
Gujarat Alkalies paid ₹26,000 for a 26% stake in FPEL Bhanu, an SPV set up for a captive wind-solar project. The SPV has not yet begun operations.
- Value
- ₹0.00 Cr
- wind capacity
- 19.8 MW
Oval Projects Engineering Merger & Restructuring Worth ₹0.05 Cr
Oval Projects announced the incorporation of Oval Eiko Resources Private Limited, a 50:50 joint venture with Eiko Scientific Solutions LLP. The JV's initial share capital is ₹5 lakh (₹0.05 Cr).
- Value
- ₹0.05 Cr
Vishnu Chemicals Merger & Restructuring
Vishnu Chemicals reports the voluntary winding up and dissolution of its step-down subsidiary VCHEM Trading FZE in Dubai. The subsidiary's FY 2025-26 revenue was nil.
Power Finance Corporation Merger & Restructuring
PFC incorporated Mahasamund Power Transmission Limited as an SPV of PFCCL for 400KV transmission project preparation. The SPV transfers to the winning bidder post competitive bidding.
EID Parry (India) Merger & Restructuring Worth ₹45.9 Cr
EID Parry approved a slump sale of its Sivagangai Distillery Unit to SVRAJU Agro Private Limited for ₹45.90 Crore. The going-concern deal, expected in three months, advances its asset rationalisation.
- Value
- ₹45.90 Cr